Cipla has reported results for the fourth quarter and year ended March 31, 2019.
The company has reported around 3-fold jump in its net profit at Rs 634.07 crore for the quarter ended March 31, 2019 as compared to Rs 224.81 crore for the same quarter in the previous year. Total income of the company increased by 27.35% at Rs 3,550.92 crore for quarter under review as compared to Rs 2,788.22 crore for the quarter ended March 31, 2018.
On consolidated basis, the company has reported over 2-fold jump in its net profit at Rs 373.60 crore for the quarter ended March 31, 2019 as compared to Rs 153.19 crore for the corresponding quarter in the FY18. Total consolidated income of the company rose 20.37% at Rs 4,499.34 crore for quarter under review as compared to Rs 3,737.98 crore for the same quarter ended previous year.
For the year ended March 31, 2019, the company has posted a rise of 28.59% in its net profit at Rs 1,888.41 crore as compared to Rs 1,468.52 crore for the previous year. Total income of company increased 9.95% at Rs 12,951.53 crore for year under review as compared to Rs 11,779.69 crore for year ended March 31, 2018.
For the year ended March 31, 2019, on the consolidated basis, the company has posted rise of 6.36% in its net profit at Rs 1,509.61 crore as compared to Rs 1,419.35 crore for the previous year. Total income of company increased by 8.10% at Rs 16,838.98 crore for year under review as compared to Rs 15,576.90 crore for year ended March 31, 2018.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: